Companies / BOC Sciences / Solanezumab
BOC Sciences

Solanezumab | BOC Sciences

Solanezumab is a humanized monoclonal IgG1 antibody that binds to the mid-domain of soluble amyloid _ peptide. Solanezumab has been used in research of Alzheimer's disease (AD) therapy.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
  • See More